Wells Fargo
STIM icon

Wells Fargo’s Neuronetics STIM Stock Holding History

Wells Fargo’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$195 Sell
150
-13,502
-99% -$19.6K ﹤0.01% 6594
2026
Q1 		$19.8K Sell
13,652
-29,639
-68% -$47K ﹤0.01% 5774
2025
Q4 		$59.7K Buy
43,291
+19,178
+80% +$40.1K ﹤0.01% 5536
2025
Q3 		$65.8K Sell
24,113
-15,475
-39% -$55K ﹤0.01% 5473
2025
Q2 		$138K Buy
39,588
+31,438
+386% +$124K ﹤0.01% 4991
2025
Q1 		$30K Buy
+8,150
New +$29.8K ﹤0.01% 5570
2024
Q2 		– Sell
-10,215
Closed -$48.6K – 7436
2024
Q1 		$48.6K Buy
10,215
+4
+0% +$14 ﹤0.01% 5263
2023
Q4 		$29.6K Buy
10,211
+10,011
+5,006% +$15.8K ﹤0.01% 5481
2023
Q3 		$270 Sell
200
-5
-2% -$9 ﹤0.01% 6510
2023
Q2 		$441 Buy
205
+17
+9% +$41 ﹤0.01% 6512
2023
Q1 		$547 Buy
188
+3
+2% +$15 ﹤0.01% 6532
2022
Q4 		$1.27K Buy
185
+6
+3% +$28 ﹤0.01% 6114
2022
Q3 		$1K Hold
179
– – ﹤0.01% 6464
2022
Q2 		$1K Sell
179
-14,821
-99% -$43K ﹤0.01% 6601
2022
Q1 		$45K Sell
15,000
-8,899
-37% -$30.1K ﹤0.01% 5708
2021
Q4 		$106K Sell
23,899
-189,437
-89% -$928K ﹤0.01% 5598
2021
Q3 		$1.4M Sell
213,336
-313,364
-59% -$3.01M ﹤0.01% 3955
2021
Q2 		$8.44M Buy
526,700
+14,777
+3% +$204K ﹤0.01% 2361
2021
Q1 		$6.33M Buy
511,923
+502,628
+5,408% +$7.71M ﹤0.01% 2608
2020
Q4 		$103K Buy
9,295
+1,206
+15% +$9.06K ﹤0.01% 5348
2020
Q3 		$39K Buy
8,089
+6,430
+388% +$24.4K ﹤0.01% 5598
2020
Q2 		$3K Sell
1,659
-35,540
-96% -$72.9K ﹤0.01% 6060
2020
Q1 		$70K Buy
37,199
+14,413
+63% +$45.1K ﹤0.01% 5225
2019
Q4 		$102K Sell
22,786
-462,563
-95% -$2.87M ﹤0.01% 5288
2019
Q3 		$4.03M Buy
485,349
+92,112
+23% +$1.01M ﹤0.01% 2732
2019
Q2 		$4.92M Buy
393,237
+64,648
+20% +$914K ﹤0.01% 2589
2019
Q1 		$5.01M Sell
328,589
-10,272
-3% -$170K ﹤0.01% 2549
2018
Q4 		$6.56M Sell
338,861
-8,362
-2% -$184K ﹤0.01% 2185
2018
Q3 		$11.1M Buy
347,223
+56,583
+19% +$1.72M ﹤0.01% 1991
2018
Q2 		$7.73M Buy
+290,640
New +$7.9M ﹤0.01% 2281

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wells Fargo's STIM Position: Q2 2026 in Review

Wells Fargo reduced its Neuronetics (STIM) stake by 99% in Q2 2026, selling an estimated $19.6K and leaving 150 shares worth $195. The position accounts for ﹤0.01% of the portfolio, ranked #6594.

Wells Fargo first reported a position in STIM in Q2 2018 and has held it in 30 quarters since. The position peaked at $11.1M in Q3 2018. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Wells Fargo held 150 shares of Neuronetics worth $195 as of Q2 2026.
  • Wells Fargo sold 13,502 Neuronetics shares in Q2 2026, an estimated $19.6K.
  • Neuronetics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6594 holding.
  • Wells Fargo first reported a position in Neuronetics in Q2 2018 and has held it in 30 quarters since.
  • Wells Fargo's Neuronetics position peaked at $11.1M in Q3 2018.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.